Berkshire Capital Holdings Inc Crispr Therapeutics Ag Transaction History

Berkshire Capital Holdings Inc

  • $233 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$70.09 - $111.29 $700 - $1,112
-10 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$110.2 - $156.64 $6.27 Million - $8.91 Million
-56,910 Reduced 99.98%
10 $1,000
Q2 2021

Aug 13, 2021
BUY
$100.84 - $161.89 $5.74 Million - $9.21 Million
56,910 Added 569100.0%
56,920 $9.22 Million
Q1 2021

May 14, 2021
BUY
$110.72 - $210.04 $1,107 - $2,100
10 New
10 $1,000

Others Institutions Holding CRSP

# of Institutions
503
Shares Held
57.1M
Call Options Held
1.74M
Put Options Held
1.83M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.96B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Berkshire Capital Holdings Inc Portfolio

Follow Berkshire Capital Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Berkshire Capital Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Berkshire Capital Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email